LON/0Q15 (LON/0Q15)

London Stock Exchange: LON/0Q15 · USD

$103

-0.29 (-0.3%)· Recorded snapshot

Market cap	133.9B
Revenue (ttm)	36.3B
Net income (ttm)	3.5B
EPS (ttm)	$2.02
P/E (trailing)	38.3x
P/E (forward)	17.5x
Dividend	$1.90 (2.45%)
Volume	6,012
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 36.3B
Net income (ttm): 3.5B
EPS (ttm): $2.02
P/E (trailing): 38.3x
P/E (forward): 17.5x
Market cap: 133.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17.5

P25 n/aP50 n/aP75 n/a

Trailing P/E38.3

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All LON/0Q15 indicators

Market & fundamental data

Available fields

244

Groups with data

Currency

USD

Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-10-21
Employees	115,000
Employees change	7,000
Employees growth	6.09%
Enterprise value	$154.7B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1888
Industry	Medical Devices
Is primary listing	No
ISIN number	US0028241000
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Last stock split date	1998-06-01
Last stock split type	Forward
Market cap	$133.9B
Price	$103.02
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	lon/0Q15
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	50.21x
Average P/E ratio (3Y)	27.41x
Average P/E ratio (5Y)	28.1x
Earnings yield	2.61%
EV/Earnings	43.98x
EV/EBIT	25.83x
EV/EBITDA	16.7x
EV/FCF	26.31x
EV/Sales	4.27x
FCF / EV yield	3.8%
FCF yield	4.39%
Forward P/E	17.55x
Graham number	42.83771
Graham upside	-58.53%
Industry forward P/E	13.68x
Industry P/E	21.46x
Lynch fair value	$13.57
Lynch upside	-86.86%
P/(FCF - SBC) ratio	25.07x
P/(OCF - SBC) ratio	19.39x
P/B ratio	3.44x
P/E ratio	38.29x
P/FCF ratio	22.77x
P/OCF ratio	17.99x
P/S ratio	3.69x
Price/EBITDA ratio	14.89x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.55%
EBITDA margin	24.79%
Effective tax rate	28.36%
FCF margin	16.8%
Gross margin	57.08%
Operating margin	16.55%
Pretax margin	13.61%
Profit margin	9.75%
Profit per employee	$30,634
Profitable quarters	34
Profitable years	35
Revenue per employee	$315,892
ROA	5.33%
ROA (5Y)	6.84%
ROCE	9.01%
ROE	10.58%
ROE (5Y)	19.7%
ROIC	7.25%
ROIC (5Y)	14.92%
SBC / revenue	1.54%
Tax / revenue	3.86%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-66.24%
EPS growth (Q)	-43.69%
EPS growth (QoQ)	-0.12%
EPS growth 10Y	11.38%
EPS growth 3Y	-2.87%
EPS growth 5Y	-7.76%
EPS growth years	0
FCF growth	15.48%
FCF growth 3Y	12.55%
FCF growth 5Y	-1.97%
Gross profit growth	12.07%
Gross profit growth (Q)	17.95%
Gross profit growth 3Y	7.75%
Gross profit growth 5Y	2.62%
Net income growth	-66.37%
Net income growth (Q)	-44.04%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	-3.11%
Net income growth 5Y	-8.3%
Net income growth years	0
OCF growth	9.61%
OCF growth 10Y	13.31%
OCF growth 3Y	9.95%
OCF growth 5Y	-1.4%
Operating income growth	-5.19%
Operating income growth (Q)	-33.06%
Operating income growth 3Y	5.37%
Operating income growth 5Y	-2.23%
Revenue growth	10%
Revenue growth (Q)	14.46%
Revenue growth (QoQ)	3.34%
Revenue growth 10Y	8.82%
Revenue growth 3Y	6.47%
Revenue growth 5Y	2.65%
Revenue growth quarters	11
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.6B
Depreciation and amortization	$3B
EBIT	$6B
EBITDA	$9B
EPS	$2.02
Financing cash flow	$8B
Free cash flow	$5.9B
Free cash flow minus SBC	$5.3B
Gross profit	$20.7B
Income taxes	$1.4B
Investing cash flow	$-16.8B
Net borrowing	$12.4B
Net cash flow	$-1.4B
Net income	$3.5B
Operating cash flow minus SBC	$6.9B
Operating income	$6B
Revenue	$36.3B
Stock-based compensation	$540.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$22.25
Debt / EBITDA	2.65
Debt / equity	0.63
Debt / FCF	4.19
Interest coverage	7.87
Net cash (debt)	$-20.4B
Net cash / market cap	-15.24%
Net debt / EBITDA	2.27
Net debt / equity	0.52
Net debt / FCF	3.47
Piotroski F-Score	5
Shareholders' equity	$39B
Tangible book value	$-1B
Tangible book value per share	$-0.59
Total cash	$4.2B
Total debt	$24.6B
WACC	6.64%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.38
Inventory turnover	2.82
Quick ratio	0.8
Working capital	$5B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.25%
Dividend growth	6.78%
Dividend growth (10Y)	9.25%
Dividend growth (3Y)	7.3%
Dividend growth (5Y)	6.96%
Dividend growth years	12
Dividend payment date	2026-11-16
Dividend payment years	35
Dividend payout frequency	Quarterly
Dividend per share	$1.90
Dividend yield	2.45%
Ex-dividend date	2026-10-15
Last dividend	$0.63
Payout ratio	93.96%
Shareholder yield	2.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	157.37%
10Y return CAGR	12.08%
10Y total return	212.88%
150-day SMA	$98.67
15Y price change	88.76%
15Y return CAGR	6.51%
15Y total return	157.72%
1D price change	-0.28%
1M price change	2.24%
1M total return	2.87%
1W price change	0.48%
1W total return	0.48%
1Y price change	-18.85%
1Y return CAGR	-16.84%
1Y total return	-16.83%
20-day SMA	$101.42
200-day SMA	$102.04
3M price change	-2.05%
3M total return	-1.44%
3Y price change	11.19%
3Y return CAGR	5.8%
3Y total return	18.44%
50-day SMA	$104.83
50-day SMA vs 200-day SMA	50over200
52-week high	$132.00
52-week high date	2025-11-18
52-week low	$82.05
52-week low date	2026-05-12
5Y price change	-19.29%
5Y return CAGR	-2.27%
5Y total return	-10.84%
6M price change	11.64%
6M total return	13.12%
All-time high	$142.15
All-time high date	2021-12-28
All-time low	$7.31
All-time low date	1992-06-12
Average true range (ATR)	$3.71
Average volume	12.4K
Beta (5Y)	0.58
Change from 52-week high	-21.95%
Change from 52-week low	25.56%
Change from all-time high	-27.32%
Change from all-time low	1,312.69%
Change from open	1%
Day's gap	-1.27%
Dollar volume	$619,356
High price	$105.00
Low price	$101.25
Monthly RSI	45.7
Open price	$102.00
Position in 52-week range	47.2%
Previous close	$103.31
Price vs 150-day SMA	4.71%
Price vs 20-day SMA	1.86%
Price vs 200-day SMA	1.25%
Price vs 50-day SMA	-1.45%
Relative volume	0.47
RSI	51.25
Sharpe ratio	-0.65
Sharpe ratio (3Y)	0.2
Sharpe ratio (5Y)	-0.08
Sortino ratio	-0.71
Sortino ratio (3Y)	0.53
Sortino ratio (5Y)	0.13
Volume	6K
Weekly RSI	49.38
YTD price change	-17.89%
YTD total return	-15.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.7B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.25%
Shares held by insiders	0.5%
Shares held by institutions	80.99%
Short ratio	1.9 days

Deeper analysis on LON/0Q15

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this LON/0Q15 report

Is a complete LON/0Q15 research report available?

No complete published report is available for lon/0Q15 (LON/0Q15) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

133.9B

Revenue (ttm)

36.3B

Net income (ttm)

3.5B

EPS (ttm)

$2.02

P/E (trailing)

38.3x

P/E (forward)

17.5x

Dividend

$1.90 (2.45%)

Volume

6,012

Beta

0.58

Metric

Value

Amount currency

GBP

Country

United States

Country code

Earnings date

2026-10-21

Employees

115,000

Employees change

7,000

Employees growth

6.09%

Enterprise value

$154.7B

Exchange

London Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1888

Industry

Medical Devices

Is primary listing

ISIN number

US0028241000

Last earnings date

2026-10-21

Last refreshed

2026-10-28

Last stock split date

1998-06-01

Last stock split type

Forward

Market cap

$133.9B

Price

$103.02

Price currency

USD

Sector

Healthcare

SIC code

3845

Stock price date

2026-10-28

Symbol

lon/0Q15

Website

https://www.abbott.com

Metric

Value

Average P/E ratio (10Y)

50.21x

Average P/E ratio (3Y)

27.41x

Average P/E ratio (5Y)

28.1x

Earnings yield

2.61%

EV/Earnings

43.98x

EV/EBIT

25.83x

EV/EBITDA

16.7x

EV/FCF

26.31x

EV/Sales

4.27x

FCF / EV yield

3.8%

FCF yield

4.39%

Forward P/E

17.55x

Graham number

42.83771

Graham upside

-58.53%

Industry forward P/E

13.68x

Industry P/E

21.46x

Lynch fair value

$13.57

Lynch upside

-86.86%

P/(FCF - SBC) ratio

25.07x

P/(OCF - SBC) ratio

19.39x

P/B ratio

3.44x

P/E ratio

38.29x

P/FCF ratio

22.77x

P/OCF ratio

17.99x

P/S ratio

3.69x

Price/EBITDA ratio

14.89x

Sector forward P/E

14.52x

Sector P/E

22.58x

Metric

Value

EBIT margin

16.55%

EBITDA margin

24.79%

Effective tax rate

28.36%

FCF margin

16.8%

Gross margin

57.08%

Operating margin

16.55%

Pretax margin

13.61%

Profit margin

9.75%

Profit per employee

$30,634

Profitable quarters

Profitable years

Revenue per employee

$315,892

ROA

5.33%

ROA (5Y)

6.84%

ROCE

9.01%

ROE

10.58%

ROE (5Y)

19.7%

ROIC

7.25%

ROIC (5Y)

14.92%

SBC / revenue

1.54%

Tax / revenue

3.86%

Metric

Value

EPS growth

-66.24%

EPS growth (Q)

-43.69%

EPS growth (QoQ)

-0.12%

EPS growth 10Y

11.38%

EPS growth 3Y

-2.87%

EPS growth 5Y

-7.76%

EPS growth years

FCF growth

15.48%

FCF growth 3Y

12.55%

FCF growth 5Y

-1.97%

Gross profit growth

12.07%

Gross profit growth (Q)

17.95%

Gross profit growth 3Y

7.75%

Gross profit growth 5Y

2.62%

Net income growth

-66.37%

Net income growth (Q)

-44.04%

Net income growth (QoQ)

-0.86%

Net income growth 3Y

-3.11%

Net income growth 5Y

-8.3%

Net income growth years

OCF growth

9.61%

OCF growth 10Y

13.31%

OCF growth 3Y

9.95%

OCF growth 5Y

-1.4%

Operating income growth

-5.19%

Operating income growth (Q)

-33.06%

Operating income growth 3Y

5.37%

Operating income growth 5Y

-2.23%

Revenue growth

10%

Revenue growth (Q)

14.46%

Revenue growth (QoQ)

3.34%

Revenue growth 10Y

8.82%

Revenue growth 3Y

6.47%

Revenue growth 5Y

2.65%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

$-1.6B

Depreciation and amortization

$3B

EBIT

$6B

EBITDA

$9B

EPS

$2.02

Financing cash flow

$8B

Free cash flow

$5.9B

Free cash flow minus SBC

$5.3B

Gross profit

$20.7B

Income taxes

$1.4B

Investing cash flow

$-16.8B

Net borrowing

$12.4B

Net cash flow

$-1.4B

Net income

$3.5B

Operating cash flow minus SBC

$6.9B

Operating income

$6B

Revenue

$36.3B

Stock-based compensation

$540.3M

Metric

Value

Book value per share

$22.25

Debt / EBITDA

2.65

Debt / equity

0.63

Debt / FCF

4.19

Interest coverage

7.87

Net cash (debt)

$-20.4B

Net cash / market cap

-15.24%

Net debt / EBITDA

2.27

Net debt / equity

0.52

Net debt / FCF

3.47

Piotroski F-Score

Shareholders' equity

$39B

Tangible book value

$-1B

Tangible book value per share

$-0.59

Total cash

$4.2B

Total debt

$24.6B

WACC

6.64%

Metric

Value

Asset turnover

0.48

Current ratio

1.38

Inventory turnover

2.82

Quick ratio

0.8

Working capital

$5B

Metric

Value

Buyback yield / dilution

0.25%

Dividend growth

6.78%

Dividend growth (10Y)

9.25%

Dividend growth (3Y)

7.3%

Dividend growth (5Y)

6.96%

Dividend growth years

Dividend payment date

2026-11-16

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

$1.90

Dividend yield

2.45%

Ex-dividend date

2026-10-15

Last dividend

$0.63

Payout ratio

93.96%

Shareholder yield

2.69%

Metric

Value

10Y price change

157.37%

10Y return CAGR

12.08%

10Y total return

212.88%

150-day SMA

$98.67

15Y price change

88.76%

15Y return CAGR

6.51%

15Y total return

157.72%

1D price change

-0.28%

1M price change

2.24%

1M total return

2.87%

1W price change

0.48%

1W total return

0.48%

1Y price change

-18.85%

1Y return CAGR

-16.84%

1Y total return

-16.83%

20-day SMA

$101.42

200-day SMA

$102.04

3M price change

-2.05%

3M total return

-1.44%

3Y price change

11.19%

3Y return CAGR

5.8%

3Y total return

18.44%

50-day SMA

$104.83

50-day SMA vs 200-day SMA

50over200

52-week high

$132.00

52-week high date

2025-11-18

52-week low

$82.05

52-week low date

2026-05-12

5Y price change

-19.29%

5Y return CAGR

-2.27%

5Y total return

-10.84%

6M price change

11.64%

6M total return

13.12%

All-time high

$142.15

All-time high date

2021-12-28

All-time low

$7.31

All-time low date

1992-06-12

Average true range (ATR)

$3.71

Average volume

12.4K

Beta (5Y)

0.58

Change from 52-week high

-21.95%

Change from 52-week low

25.56%

Change from all-time high

-27.32%

Change from all-time low

1,312.69%

Change from open

Day's gap

-1.27%

Dollar volume

$619,356

High price

$105.00

Low price

$101.25

Monthly RSI

45.7

Open price

$102.00

Position in 52-week range

47.2%

Previous close

$103.31

Price vs 150-day SMA

4.71%

Price vs 20-day SMA

1.86%

Price vs 200-day SMA

1.25%

Price vs 50-day SMA

-1.45%

Relative volume

0.47

RSI

51.25

Sharpe ratio

-0.65

Sharpe ratio (3Y)

0.2

Sharpe ratio (5Y)

-0.08

Sortino ratio

-0.71

Sortino ratio (3Y)

0.53

Sortino ratio (5Y)

0.13

Volume

Weekly RSI

49.38

YTD price change

-17.89%

YTD total return

-15.84%

Metric

Value

Float

1.7B

Shares change (QoQ)

-0.29%

Shares change (YoY)

-0.25%

Shares held by insiders

0.5%

Shares held by institutions

80.99%

Short ratio

1.9 days

LON/0Q15 (LON/0Q15)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0Q15

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0Q15 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0Q15

Frequently asked questions

LON/0Q15 (LON/0Q15)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0Q15

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0Q15 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0Q15

Frequently asked questions